Biotech Insider

    Invest in the Future of Medicine

    30-day money-back guarantee · Instant access

    Biotech Insider

    About Biotech Insider

    Risk Advisory

    Long-term Growth

    Market Sector

    Medical/Biotech

    Category

    Micro/Small/Mid Cap

    Biotech Insider provides research on stocks of small biotech companies. The biotech sector offers small investors a unique advantage over large institutional investors and mutual funds, which typically consider the stocks too small to research, monitor or invest in.

    Product Strategy: Growth

    • Biotech Insider looks for small and mid-cap companies that are participating in late phase II and phase III clinical trials. To mitigate risk, we focus primarily on companies that are near the end of a clinical trial cycle.
    • However, occasionally we will initiate research and analysis on companies that do not meet this profile if they have great science of a broad-based approach. While these companies may be further from commercialization, they can represent savvy investments for the patient investor.

    What You Get Inside

    Everything unlocks the moment your order goes through.

    Model Portfolio

    Every open position you can follow, with every buy and sell recorded.

    Research Library

    Every in-depth report, with new ones added regularly.

    Trade Alerts

    Know right away when we buy, sell or change a position.

    Portfolio Updates

    Monthly portfolio reviews and 24/7 access to the members-only area.

    Dylan Jovine, founder of Behind the Markets
    Founded by Dylan Jovine

    30+ years in the markets, focused on independent research for individual investors.

    Membership Options

    Choose Your Plan

    Every plan includes the same Biotech Insider research. Pick how long you'd like access.

    Annual

    12 months of access

    $2,997

    30-day money-back guarantee

    • Model portfolio & full report library
    • Trade alerts & portfolio updates
    • One payment covers 12 months

    2-Year

    2 years of access

    $3,997
    Save $1,997 vs. paying yearly

    30-day money-back guarantee

    • Model portfolio & full report library
    • Trade alerts & portfolio updates
    • One payment covers 2 years
    Best Value

    VIP Unlimited

    Access for the life of the publication

    $4,997

    One payment. Never renews.

    No renewal fees, ever

    30-day money-back guarantee

    • Model portfolio & full report library
    • Trade alerts & portfolio updates
    • One payment, no renewals
    Annual2-YearVIP
    Access1 yr2 yrsLifetime
    Per year$2,997$1,999No Renewal
    30DAYGUARANTEE

    Try it for 30 days, risk-free.

    If Biotech Insider isn't right for you, contact us within 30 days for a full refund.

    Questions Before You Join

    Right away. As soon as your order goes through you'll get a welcome email, and everything is waiting when you sign in to your account.

    Not ready yet?

    Get our free market updates by email and decide later.